Annual report
4588.TEDINET S100PNC1
Period2020-01-01 → 2020-12-31
Filed2022-11-17
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Amends S100L1LQ.
Key figures · 78
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥314m | 2020-01-01 → 2020-12-31 | Standalone | Net sales |
| Revenue | ¥1.3bn | 2019-01-01 → 2019-12-31 | Standalone | Net sales |
| Revenue | ¥169m | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥229m | 2017-01-01 → 2017-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥178m | 2016-01-01 → 2016-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥1.7bn | 2020-01-01 → 2020-12-31 | Standalone | Operating income |
| Operating income | −¥511m | 2019-01-01 → 2019-12-31 | Standalone | Operating income |
| Ordinary income | −¥1.7bn | 2020-01-01 → 2020-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥539m | 2019-01-01 → 2019-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.2bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2017-01-01 → 2017-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥864m | 2016-01-01 → 2016-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥2.1bn | 2020-01-01 → 2020-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥909m | 2019-01-01 → 2019-12-31 | Standalone | Income before income taxes |
| Net income | −¥2.1bn | 2020-01-01 → 2020-12-31 | Standalone | Profit loss |
| Net income | −¥912m | 2019-01-01 → 2019-12-31 | Standalone | Profit loss |
| Net income | −¥1.2bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.1bn | 2017-01-01 → 2017-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥931m | 2016-01-01 → 2016-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.8bn | at 2020-12-31 | Standalone | Assets |
| Total assets | ¥4.4bn | at 2019-12-31 | Standalone | Assets |
| Total assets | ¥3.4bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.5bn | at 2017-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2016-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥793m | at 2020-12-31 | Standalone | Liabilities |
| Total liabilities | ¥926m | at 2019-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.0bn | at 2020-12-31 | Standalone | Net assets |
| Net assets / equity | ¥3.5bn | at 2019-12-31 | Standalone | Net assets |
| Net assets / equity | ¥2.9bn | at 2018-12-31d | Standalone | Net assets |
| Net assets / equity | ¥2.9bn | at 2017-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.6bn | at 2016-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2020-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.3bn | at 2019-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.8bn | at 2020-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2019-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2018-12-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2017-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.4bn | at 2016-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥1.5bn | 2020-01-01 → 2020-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥238m | 2019-01-01 → 2019-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.2bn | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2017-01-01 → 2017-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥903m | 2016-01-01 → 2016-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥38m | 2020-01-01 → 2020-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥4m | 2019-01-01 → 2019-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥342m | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥132m | 2017-01-01 → 2017-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥257m | 2016-01-01 → 2016-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥242m | 2020-01-01 → 2020-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2019-01-01 → 2019-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2017-01-01 → 2017-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6m | 2016-01-01 → 2016-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-145.58 | 2020-01-01 → 2020-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-65.55 | 2019-01-01 → 2019-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-104.55 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-106.23 | 2017-01-01 → 2017-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-101.18 | 2016-01-01 → 2016-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥136.43 | at 2020-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥240.71 | at 2019-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥216.61 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥263.54 | at 2017-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥283.43 | at 2016-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 71.4% | at 2020-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2019-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.3% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.9% | at 2017-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.7% | at 2016-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 14,641,900 | at 2020-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,331,300 | at 2019-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 13,346,000 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,086,000 | at 2017-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,234,600 | at 2016-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 32 | at 2020-12-31 | Standalone | Number of employees |
| Employees | 27 | at 2019-12-31 | Standalone | Number of employees |
| Employees | 30 | at 2018-12-31d | Standalone | Number of employees |
| Employees | 29 | at 2017-12-31d | Standalone | Number of employees |
| Employees | 30 | at 2016-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2020-01-01 → 2020-12-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2020-01-01 → 2020-12-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2020-12-31 | ¥2.7bn |
| Reconciling Itemsreconciling | segment profit | 2020-01-01 → 2020-12-31 | −¥888m |
| Diagnostic Divisionreportable segment | capex | 2020-01-01 → 2020-12-31 | ¥14m |
| Diagnostic Divisionreportable segment | depreciation | 2020-01-01 → 2020-12-31 | ¥2m |
| Diagnostic Divisionreportable segment | employees | at 2020-12-31 | 2 pure |
| Diagnostic Divisionreportable segment | revenue | 2020-01-01 → 2020-12-31 | ¥610,000 |
| Diagnostic Divisionreportable segment | revenue external | 2020-01-01 → 2020-12-31 | ¥610,000 |
| Diagnostic Divisionreportable segment | segment assets | at 2020-12-31 | ¥22m |
| Diagnostic Divisionreportable segment | segment profit | 2020-01-01 → 2020-12-31 | −¥73m |
| Pharmaceutical Divisionreportable segment | employees | at 2020-12-31 | 12 pure |
| Pharmaceutical Divisionreportable segment | revenue | 2020-01-01 → 2020-12-31 | ¥314m |
| Pharmaceutical Divisionreportable segment | revenue external | 2020-01-01 → 2020-12-31 | ¥314m |
| Pharmaceutical Divisionreportable segment | segment assets | at 2020-12-31 | ¥91m |
| Pharmaceutical Divisionreportable segment | segment profit | 2020-01-01 → 2020-12-31 | −¥713m |
| —segment total | employees | at 2020-12-31 | 14 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-01-01 → 2020-12-31 | ¥14m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-01-01 → 2020-12-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-01-01 → 2020-12-31 | ¥314m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-01-01 → 2020-12-31 | ¥314m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2020-12-31 | ¥113m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-01-01 → 2020-12-31 | −¥787m |
| Reconciling Itemsreconciling | capex | 2019-01-01 → 2019-12-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2019-01-01 → 2019-12-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2019-12-31 | ¥3.9bn |
| Reconciling Itemsreconciling | segment profit | 2019-01-01 → 2019-12-31 | −¥733m |
| Diagnostic Divisionreportable segment | capex | 2019-01-01 → 2019-12-31 | ¥10m |
| Diagnostic Divisionreportable segment | depreciation | 2019-01-01 → 2019-12-31 | ¥303,000 |
| Diagnostic Divisionreportable segment | revenue | 2019-01-01 → 2019-12-31 | ¥11m |
| Diagnostic Divisionreportable segment | revenue external | 2019-01-01 → 2019-12-31 | ¥11m |
| Diagnostic Divisionreportable segment | segment assets | at 2019-12-31 | ¥10m |
| Diagnostic Divisionreportable segment | segment profit | 2019-01-01 → 2019-12-31 | −¥152m |
| Pharmaceutical Divisionreportable segment | revenue | 2019-01-01 → 2019-12-31 | ¥1.3bn |
| Pharmaceutical Divisionreportable segment | revenue external | 2019-01-01 → 2019-12-31 | ¥1.3bn |
| Pharmaceutical Divisionreportable segment | segment assets | at 2019-12-31 | ¥420m |
| Pharmaceutical Divisionreportable segment | segment profit | 2019-01-01 → 2019-12-31 | ¥373m |
| Total Of Reportable Segments And Otherssegment total | capex | 2019-01-01 → 2019-12-31 | ¥10m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2019-01-01 → 2019-12-31 | ¥303,000 |
| Total Of Reportable Segments And Otherssegment total | revenue | 2019-01-01 → 2019-12-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2019-01-01 → 2019-12-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2019-12-31 | ¥430m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2019-01-01 → 2019-12-31 | ¥221m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 952
| Item | Context | Value | Unit |
|---|---|---|---|
| Major components of selling general and administrative expenses (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Breakdown of loss on valuation of securities (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Description of significant transactions not requiring use of cash or cash equivalents (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes leases financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes derivatives financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes equity in earnings losses of affiliates if equity method is applied financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of reportable segments (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Explanation of measurements of sales profit loss asset liability and other items for each reportable segment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each product or service (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Revenues from external customers information for each region (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Property plant and equipment information for each region (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each of main customers (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Description of impairment loss not allocated to reportable segments | CurrentYearDuration_NonConsolidatedMember | Original text (Japanese)（注）「全社」の金額は、セグメントに帰属しない全社資産に係る減損損失であります。 | |
| Description of amortization of goodwill or unamortized balance of goodwill not allocated to reportable segments | CurrentYearDuration_NonConsolidatedMember | Original text (Japanese)【報告セグメントごとののれんの償却額及び未償却残高に関する情報】該当事項はありません。 | |
| Description of factors which led to recognition of gain on bargain purchase (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes related parties financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of property plant and equipment etc (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of corporate bonds financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of borrowings financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of provisions (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Components of major assets and liabilities (text) | CurrentYearDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Overview of operational procedures for shares (text) | FilingDateInstant | Text · Plus | |
| Information about parent company etc of reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |